Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.
about
Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms.Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.Infant with a skin lesion and respiratory distress.V600E mutation detected in a case of Rosai-Dorfman disease
P2860
Real-time genomic profiling of histiocytoses identifies early-kinase domain BRAF alterations while improving treatment outcomes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Real-time genomic profiling of ...... improving treatment outcomes.
@en
Real-time genomic profiling of ...... improving treatment outcomes.
@nl
type
label
Real-time genomic profiling of ...... improving treatment outcomes.
@en
Real-time genomic profiling of ...... improving treatment outcomes.
@nl
prefLabel
Real-time genomic profiling of ...... improving treatment outcomes.
@en
Real-time genomic profiling of ...... improving treatment outcomes.
@nl
P2093
P2860
P1433
P1476
Real-time genomic profiling of ...... e improving treatment outcomes
@en
P2093
Anjelika Gasilina
Ashish R Kumar
Francis X McCormack
Jason Clark
Jayeeta Roychoudhury
Jeffrey S Ross
Mark Bailey
Michael S Grimley
Nicolas N Nassar
Philip Stephens
P2860
P304
P356
10.1172/JCI.INSIGHT.89473
P577
2017-02-09T00:00:00Z